29th Mar 2017 11:00
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
|
| |||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: | BioPharma Credit PLC | |||
2. Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights |
| |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |||
An event changing the breakdown of voting rights |
| |||
Other (please specify): Placing of New Shares |
| x | ||
3. Full name of person(s) subject to thenotification obligation: | Prudential plc group of companies
| |||
4. Full name of shareholder(s) (if different from 3.): |
Prudential plc The Prudential Assurance Company Limited M&G Group Limited M&G Limited M&G Investment Management Limited
| |||
5. Date of the transaction and date onwhich the threshold is crossed orreached: | 27 March 2017 | |||
6. Date on which issuer notified: | 28 March 2017 | |||
7. Threshold(s) that is/are crossed orreached: | 20% | |||
8. Notified details: | |||||||||||||||
A: Voting rights attached to shares | |||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | |||||||||||
Direct | Direct | Indirect | Direct | Indirect | |||||||||||
ORD USD0.01 GB00BDGKMY29 | Below 5% | Below 5% | 109,000,000 | 0 | 109,000,000 | 0 | 20.69% | ||||||||
| |||||||||||||||
B: Qualifying Financial Instruments | |||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||
Type of financialinstrument | Expirationdate | Exercise/Conversion Period | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||||||
|
|
|
|
| |||||||||||
| |||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||||
Resulting situation after the triggering transaction | |||||||||||||||
Type of financialinstrument | Exercise price | Expiration date | Exercise/Conversion period | Number of voting rights instrument refers to
| % of voting rights
| ||||||||||
|
|
|
|
| Nominal | Delta | |||||||||
|
| ||||||||||||||
| |||||||||||||||
Total (A+B+C) | |||||||||||||||
Number of voting rights | Percentage of voting rights | ||||||||||||||
109,000,000 | 20.69% | ||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | ||
Prudential plc (parent Company) - 109,000,000 (20.69%) The Prudential Assurance Company Limited (wholly owned subsidiary of Prudential plc) - 104,665,724 (19.87%) M&G Group Limited (wholly owned subsidiary of Prudential plc) - 109,000,000 (20.69%) M&G Limited (wholly owned subsidiary of M&G Group Limited) - 109,000,000 (20.69%) M&G Investment Management Limited (wholly owned subsidiary of M&G Limited) - 109,000,000 (20.69%)
| ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | N/A | |
11. Number of voting rights proxy holder will ceaseto hold: | N/A | |
12. Date on which proxy holder will cease to holdvoting rights: | N/A | |
| ||
13. Additional information: |
| |
14. Contact name: | John Baker / Owen Smith / James Todd M&G Investment Management Limited | |
15. Contact telephone number: | 020 7548 2561 / 020 7004 4517 / 020 7548 2293 | |
Related Shares:
Biopharma Cred.Prudential